Too much tolerance for hyperoxemia in mechanically ventilated patients with SARS-CoV-2 pneumonia? Report from an Italian intensive care unit.
ARDS
COVID-19
SARS-CoV-2
hyperoxia
oxygen
ventilator-associated pneumonia
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
31
05
2022
accepted:
06
07
2022
entrez:
15
8
2022
pubmed:
16
8
2022
medline:
16
8
2022
Statut:
epublish
Résumé
In COVID-19 patients requiring mechanical ventilation, the administration of high oxygen (O Retrospective single-center study on adult patients with SARS-CoV-2 pneumonia requiring invasive mechanical ventilation for ≥48 h. Patients undergoing extracorporeal respiratory support were excluded. We calculated the excess O One hundred thirty-four patients were included. For each day of mechanical ventilation, each patient received a median excess O Excess O
Sections du résumé
Background
UNASSIGNED
In COVID-19 patients requiring mechanical ventilation, the administration of high oxygen (O
Materials and methods
UNASSIGNED
Retrospective single-center study on adult patients with SARS-CoV-2 pneumonia requiring invasive mechanical ventilation for ≥48 h. Patients undergoing extracorporeal respiratory support were excluded. We calculated the excess O
Results
UNASSIGNED
One hundred thirty-four patients were included. For each day of mechanical ventilation, each patient received a median excess O
Conclusion
UNASSIGNED
Excess O
Identifiants
pubmed: 35966865
doi: 10.3389/fmed.2022.957773
pmc: PMC9365979
doi:
Types de publication
Journal Article
Langues
eng
Pagination
957773Informations de copyright
Copyright © 2022 Damiani, Casarotta, Carsetti, Mariotti, Vannicola, Giorgetti, Domizi, Scorcella, Adrario and Donati.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Respir Care. 2012 Nov;57(11):1887-93
pubmed: 22613692
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Ann Intensive Care. 2014 Jul 25;4:23
pubmed: 25512878
J Appl Physiol (1985). 2003 Mar;94(3):975-82
pubmed: 12571129
Crit Care. 2020 Mar 31;24(1):125
pubmed: 32234077
Am J Respir Cell Mol Biol. 2013 Mar;48(3):280-7
pubmed: 23087050
Crit Care. 2020 May 15;24(1):225
pubmed: 32414420
J Antimicrob Chemother. 2013 Oct;68(10):2305-10
pubmed: 23681269
Crit Care Med. 2004 May;32(5):1155-60
pubmed: 15190966
Crit Care. 2016 Jun 22;20(1):195
pubmed: 27334713
Cochrane Database Syst Rev. 2019 Nov 27;2019(11):
pubmed: 31773728
J Crit Care. 2009 Dec;24(4):515-22
pubmed: 19327314
JAMA. 2018 Feb 20;319(7):698-710
pubmed: 29466596
Mol Med. 2012 May 09;18:477-85
pubmed: 22314397
N Engl J Med. 2021 Apr 8;384(14):1301-1311
pubmed: 33471452
Chest. 2007 May;131(5):1541-9
pubmed: 17494803
Lancet. 2018 Apr 28;391(10131):1693-1705
pubmed: 29726345
Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416
pubmed: 15699079
Crit Care Med. 2018 Apr;46(4):517-524
pubmed: 29261565
Crit Care. 2021 Mar 16;25(1):106
pubmed: 33726819
JAMA. 2016 Oct 18;316(15):1583-1589
pubmed: 27706466
Am J Respir Crit Care Med. 2016 Jan 1;193(1):43-51
pubmed: 26334785
N Engl J Med. 1983 Oct 13;309(15):878-83
pubmed: 6888481
Acad Emerg Med. 2011 Oct;18(10):1099-104
pubmed: 21996075
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1560-1564
pubmed: 32348678
Crit Care. 2014 Mar 18;18(2):208
pubmed: 25029020
J Crit Care. 2013 Oct;28(5):647-54
pubmed: 23683560
Crit Care. 2016 Aug 16;20(1):239
pubmed: 27526848
N Engl J Med. 2020 Mar 12;382(11):999-1008
pubmed: 32160661
Intensive Care Med. 2011 Jan;37(1):46-51
pubmed: 20878146
Curr Opin Anaesthesiol. 2018 Apr;31(2):129-135
pubmed: 29334496
Med Intensiva. 2023 Apr;47(4):212-220
pubmed: 35528275